AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10189045 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 402
Study 7865386 — intervention group
Group type: COMPARATOR
Intervention: Iloprost
Number of subjects: 0
Study 7865386 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with cyclophosphamide and low-dose corticosteroids
Number of subjects: 0
Study 7865386 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0
Study 7865386 — intervention group
Group type: COMPARATOR
Intervention: Aminobenzoate potassium
Number of subjects: 0
Study 7865386 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin
Number of subjects: 0
Study 7865386 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal photopheresis
Number of subjects: 0
Study 7865386 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 0
Study 7865386 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine
Number of subjects: 0
Study 2744314 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexiletine (200 mg q.i.d.)
Number of subjects: 14
Study 194524 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-corticosteroid solution
Number of subjects: 239
Study 194524 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-corticosteroid suspension
Number of subjects: 239
Study 31820541 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified intention-to-treat (ITT) analysis
Number of subjects: 0
Study 31820541 — intervention group
Group type: EXPERIMENTAL
Intervention: Censoring approach
Number of subjects: 0
Study 30690531 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum appointment timing (2-3 weeks after delivery)
Number of subjects: 80
Study 30690531 — intervention group
Group type: COMPARATOR
Intervention: Postpartum appointment timing (6-8 weeks after delivery)
Number of subjects: 80
Study 30690531 — intervention group
Group type: COMPARATOR
Intervention: Workplace breastfeeding support
Number of subjects: 80
Study 30690531 — intervention group
Group type: COMPARATOR
Intervention: Unit and Army support for breastfeeding
Number of subjects: 80
Study 27611736 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (150, 300, 600, or 150 to 600 mg/day)
Number of subjects: 18
Study 27611736 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 18
Study 25954025 — intervention group
Group type: EXPERIMENTAL
Intervention: Violet syrup
Number of subjects: 182
Study 25954025 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study 23311498 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide Awake Parenting program (intervention group)
Number of subjects: 0
Study 23311498 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 21425885 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral indomethacin/prochlorperazine/caffeine
Number of subjects: 0
Study 21425885 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal indomethacin/prochlorperazine/caffeine
Number of subjects: 0
Study 17490753 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) group intervention
Number of subjects: 277
Study 17490753 — intervention group
Group type: COMPARATOR
Intervention: Control condition (information booklet)
Number of subjects: 277
Study 17490753 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT group intervention (completers)
Number of subjects: 277
Study 17490753 — intervention group
Group type: COMPARATOR
Intervention: Control condition (completers)
Number of subjects: 277
Study 16460664 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 40
Study 16460664 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensodyne
Number of subjects: 40
Study 16460664 — intervention group
Group type: COMPARATOR
Intervention: Positive control group
Number of subjects: 40
Study 16460664 — intervention group
Group type: COMPARATOR
Intervention: Negative control group
Number of subjects: 40
Study 12833107 — intervention group
Group type: EXPERIMENTAL
Intervention: High MUFA diet (40% of energy from CHOs, 25% from MUFAs)
Number of subjects: 32
Study 12833107 — intervention group
Group type: COMPARATOR
Intervention: High CHO diet (55% of energy from CHOs, 10% from MUFAs)
Number of subjects: 32
Study 12833107 — intervention group
Group type: EXPERIMENTAL
Intervention: High MUFA diet
Number of subjects: 32
Study 12833107 — intervention group
Group type: COMPARATOR
Intervention: High CHO diet
Number of subjects: 32
Study 10964199 — intervention group
Group type: COMPARATOR
Intervention: Breast disease pathway
Number of subjects: 0
Study 10964199 — intervention group
Group type: COMPARATOR
Intervention: Maternity pathway
Number of subjects: 0
Study 10964199 — intervention group
Group type: COMPARATOR
Intervention: Both pathways
Number of subjects: 0
Study 8784750 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training in men (N = 16)
Number of subjects: 44
Study 8784750 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training in women (N = 9)
Number of subjects: 44
Study 8784750 — intervention group
Group type: COMPARATOR
Intervention: Nonaerobic stretching in men (N = 11)
Number of subjects: 44
Study 8784750 — intervention group
Group type: COMPARATOR
Intervention: Nonaerobic stretching in women (N = 8)
Number of subjects: 44
Study 1460211 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide (IB) nasal spray (84 micrograms/nostril, two sprays per nostril, four times a day for 4 days)
Number of subjects: 0
Study 1460211 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide (IB) nasal spray
Number of subjects: 0
Study 6419709 — intervention group
Group type: EXPERIMENTAL
Intervention: XYY men with higher concentrations of testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH)
Number of subjects: 4591
Study 6419709 — intervention group
Group type: EXPERIMENTAL
Intervention: XXY men with higher levels of LH, FSH, and prolactin, but low testosterone
Number of subjects: 4591
Study 6419709 — intervention group
Group type: COMPARATOR
Intervention: All subjects and XY controls
Number of subjects: 4591
Study 6419709 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects divided into nondelinquents, delinquents without violent convictions, and delinquents with violent convictions
Number of subjects: 4591
Study 6419709 — intervention group
Group type: COMPARATOR
Intervention: Psychological interview and projective tests
Number of subjects: 4591
Study 6419709 — intervention group
Group type: EXPERIMENTAL
Intervention: XYY men
Number of subjects: 4591
Study 31158087 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel (75mg/m2) administered alongside standard of care (SOC) hormone therapy for ≥2 years and radiotherapy in some patients.
Number of subjects: 0
Study 31158087 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) hormone therapy for ≥2 years and radiotherapy in some patients.
Number of subjects: 0
Study 25924918 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory mucosa lamina propria (OLP) transplants (n = 8)
Number of subjects: 12
Study 25924918 — intervention group
Group type: COMPARATOR
Intervention: Sham surgery (control group, n = 4)
Number of subjects: 12
Study 24989691 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported racism
Number of subjects: 365
Study 24989691 — intervention group
Group type: EXPERIMENTAL
Intervention: Sense of control
Number of subjects: 365
Study 24989691 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived stress
Number of subjects: 365
Study 24989691 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 365
Study 22658231 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral nerve block (group F)
Number of subjects: 55
Study 22658231 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic (group L)
Number of subjects: 55
Study 20160444 — intervention group
Group type: EXPERIMENTAL
Intervention: Austrian women
Number of subjects: 1074
Study 18418653 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic surgery
Number of subjects: 95
Study 18418653 — intervention group
Group type: COMPARATOR
Intervention: Straight laparoscopic surgery
Number of subjects: 95
Study 15852407 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily radiotherapy (QDRT)
Number of subjects: 263
Study 15852407 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily radiotherapy (BIDRT)
Number of subjects: 263
Study 12774967 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 3 microg/kg PO q8h
Number of subjects: 24
Study 12774967 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 3 microg/kg PO q12h
Number of subjects: 24
Study 12774967 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 12774967 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 25 mg/kg PO q8h
Number of subjects: 24
Study 11071019 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (running)
Number of subjects: 75
Study 11071019 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine
Number of subjects: 75
Study 11071019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 9331190 — intervention group
Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy using the Summit ExciMed UV200LA excimer laser
Number of subjects: 701
Study 8420491 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azathioprine (100 to 150 mg/d) in combination with oral prednisolone (1 mg/kg per day)
Number of subjects: 100
Study 8420491 — intervention group
Group type: EXPERIMENTAL
Intervention: Four large-volume plasma exchanges in combination with oral prednisolone (1 mg/kg per day)
Number of subjects: 100
Study 8420491 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone (1 mg/kg per day) alone
Number of subjects: 100
Study 3541816 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 400 mg b.i.d. (week 1)
Number of subjects: 12
Study 3541816 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 1,200 mg b.i.d. (week 2)
Number of subjects: 12
Study 3541816 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 400 mg (superimposed dosage on day 8)
Number of subjects: 12
Study 3541816 — intervention group
Group type: EXPERIMENTAL
Intervention: Milacemide 1,200 mg (superimposed dosage on day 15)
Number of subjects: 12
Study 3541816 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic treatment (1 week and 2 weeks)
Number of subjects: 12
Study 3541816 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychometric analyses
Number of subjects: 12
Study 3541816 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychophysiological tests
Number of subjects: 12
Study 3541816 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse rate, systolic and diastolic blood pressure
Number of subjects: 12
Study 30083236 — intervention group
Group type: EXPERIMENTAL
Intervention: D-Flex measurement device
Number of subjects: 20
Study 30083236 — intervention group
Group type: COMPARATOR
Intervention: Goniometer
Number of subjects: 20
Study 30083236 — intervention group
Group type: COMPARATOR
Intervention: Inclinometer
Number of subjects: 20
Study 26429650 — intervention group
Group type: EXPERIMENTAL
Intervention: Definitive radiotherapy (DRT)
Number of subjects: 73
Study 26429650 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy (PORT)
Number of subjects: 73
Study 25478537 — intervention group
Group type: EXPERIMENTAL
Intervention: GlideScope video-laryngoscope (GVL)
Number of subjects: 60
Study 25478537 — intervention group
Group type: COMPARATOR
Intervention: Macintosh direct laryngoscope (MDL)
Number of subjects: 60
Study 22731754 — intervention group
Group type: EXPERIMENTAL
Intervention: 500/100 μg fluticasone/salmeterol Diskus daily
Number of subjects: 422
Study 22731754 — intervention group
Group type: EXPERIMENTAL
Intervention: 400/24 μg extrafine beclomethasone/formoterol pMDI daily
Number of subjects: 422
Study 22731754 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 422
Study 20092966 — intervention group
Group type: EXPERIMENTAL
Intervention: modafinil (400mg once daily)
Number of subjects: 71
Study 20092966 — intervention group
Group type: COMPARATOR
Intervention: placebo (once daily)
Number of subjects: 71
Study 18682624 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentolamine mesylate (PM) injection
Number of subjects: 152
Study 18682624 — intervention group
Group type: COMPARATOR
Intervention: Control (sham injection)
Number of subjects: 152
Study 16425390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (1 g every 6 h for 5 days)
Number of subjects: 37
Study 16425390 — intervention group
Group type: COMPARATOR
Intervention: Amikacin (500 mg once daily for 5 days)
Number of subjects: 37
Study 16425390 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 37
Study 16425390 — intervention group
Group type: COMPARATOR
Intervention: Amikacin
Number of subjects: 37
Study 14674839 — intervention group
Group type: EXPERIMENTAL
Intervention: Trace conditional discrimination learning (light conditional stimulus S+/S‐ and tone conditioned stimulus CS with 1‐s trace)
Number of subjects: 16
Study 14674839 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay conditional discrimination learning (temporal separation eliminated)
Number of subjects: 16
Study 10389550 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone 168 micrograms plus salmeterol 42 micrograms twice daily
Number of subjects: 514
Study 10389550 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone 336 micrograms twice daily
Number of subjects: 514
Study 8896506 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmonella abortus equi endotoxin (0.8 ng/kg) given intravenously at 1900 h
Number of subjects: 0
Study 8896506 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmonella abortus equi endotoxin (0.8 ng/kg) given intravenously at 0900 h
Number of subjects: 0
Study 8896506 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 1354949 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine (SL 85.0324) 2 mg to 75 mg
Number of subjects: 10
Study 1354949 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine (SL 85.0324) 10 mg
Number of subjects: 10
Study 1354949 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine (SL 85.0324) up to 75 mg
Number of subjects: 10
Study 1354949 — intervention group
Group type: EXPERIMENTAL
Intervention: Mizolastine (SL 85.0324)
Number of subjects: 10
Study 6373217 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (Dusodril) 600 mg orally
Number of subjects: 104
Study 6373217 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 31455105 — intervention group
Group type: EXPERIMENTAL
Intervention: Confederate trustee with tears (neutral or sad facial expression)
Number of subjects: 0
Study 31455105 — intervention group
Group type: EXPERIMENTAL
Intervention: Confederate recipient with tears (neutral or sad facial expression)
Number of subjects: 0
Study 30100298 — intervention group
Group type: COMPARATOR
Intervention: TENS
Number of subjects: 30
Study 30100298 — intervention group
Group type: EXPERIMENTAL
Intervention: Diadynamic current
Number of subjects: 30
Study 27555206 — intervention group
Group type: EXPERIMENTAL
Intervention: ACB with local anesthetic and buprenorphine
Number of subjects: 100
Study 27555206 — intervention group
Group type: COMPARATOR
Intervention: ACB with local anesthetic alone
Number of subjects: 100
Study 24856464 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol (400 μg)
Number of subjects: 160
Study 24856464 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (400 μg)
Number of subjects: 160
Study 24856464 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (400 μg)
Number of subjects: 160
Study 24856464 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cervical priming agent)
Number of subjects: 160
Study 24856464 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (oral, sublingual, vaginal)
Number of subjects: 160
Study 24856464 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 160
Study 21855274 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flexion mobile-bearing knee
Number of subjects: 388
Study 21855274 — intervention group
Group type: COMPARATOR
Intervention: Fixed-bearing control
Number of subjects: 388
Study 20832986 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (a serotonin-selective agonist) administered in a double-blind, randomized, placebo-controlled protocol.
Number of subjects: 42
Study 17884510 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer assisted alignment system (MICA group)
Number of subjects: 74
Study 17884510 — intervention group
Group type: COMPARATOR
Intervention: Traditional alignment guide (MIS group)
Number of subjects: 74
Study 16301343 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 14703
Study 12134097 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (EX)
Number of subjects: 167
Study 12134097 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 167
Study 11039606 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate (MPSL: 10 mg/kg body weight)
Number of subjects: 0
Study 11039606 — intervention group
Group type: EXPERIMENTAL
Intervention: MPSL followed by continuous infusion of urinary trypsin inhibitor (UTI) for 3 days
Number of subjects: 0
Study 11039606 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus administration of MPSL
Number of subjects: 0
Study 11039606 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of UTI in early postoperative phase after MPSL
Number of subjects: 0
Study 11039606 — intervention group
Group type: COMPARATOR
Intervention: Preoperative MPSL followed by UTI infusion for only one hour
Number of subjects: 0
Study 7598441 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (n = 20)
Number of subjects: 89
Study 7598441 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (n = 23)
Number of subjects: 89
Study 7598441 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Salbutamol and Ipratropium bromide (n = 24)
Number of subjects: 89
Study 7598441 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (n = 22)
Number of subjects: 89
Study 7598441 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 89
Study 7598441 — intervention group
Group type: EXPERIMENTAL
Intervention: Children aged more than 3 months
Number of subjects: 89
Study 7598441 — intervention group
Group type: EXPERIMENTAL
Intervention: Children positive for RSV infection
Number of subjects: 89
Study 2218733 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone (Prepidil Gel) applied 6 hours before abortion
Number of subjects: 73
Study 2218733 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone (Prepidil Gel) applied 4 hours before abortion
Number of subjects: 73
Study 2218733 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinoprostone (Prepidil Gel)
Number of subjects: 73
Study 340949 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 3-g oral dose of amoxicillin
Number of subjects: 61
Study 340949 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (10 days of amoxicillin, 250 mg, four times per day)
Number of subjects: 61
Study 31802534 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol TCI with BIS monitoring (BIS scores of 60-80)
Number of subjects: 200
Study 31802534 — intervention group
Group type: COMPARATOR
Intervention: Propofol TCI without BIS monitoring (BIS-blind group, monitoring scores of 1-2)
Number of subjects: 200
Study 31802534 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring
Number of subjects: 200
Study 31014435 — intervention group
Group type: EXPERIMENTAL
Intervention: Flu+Mon+Ket
Number of subjects: 280
Study 31014435 — intervention group
Group type: EXPERIMENTAL
Intervention: Ket
Number of subjects: 280
Study 31014435 — intervention group
Group type: EXPERIMENTAL
Intervention: Flu or Mon alone
Number of subjects: 280
Study 31014435 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 280
Study 28864219 — intervention group
Group type: EXPERIMENTAL
Intervention: Regenerative endodontic treatment (RET)
Number of subjects: 118
Study 28864219 — intervention group
Group type: COMPARATOR
Intervention: Apexification
Number of subjects: 118
Study 25843397 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastrojejunostomy
Number of subjects: 60
Study 25843397 — intervention group
Group type: EXPERIMENTAL
Intervention: LRYGB with a small stomach pouch
Number of subjects: 60
Study 23503480 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg/day) for 12 months
Number of subjects: 31
Study 21199980 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescents (≤19 years)
Number of subjects: 831
Study 21199980 — intervention group
Group type: COMPARATOR
Intervention: Adults (>19 years)
Number of subjects: 831
Study 18553060 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy with removable suture (group B)
Number of subjects: 66
Study 18553060 — intervention group
Group type: COMPARATOR
Intervention: Standard trabeculectomy (group A)
Number of subjects: 66
Study 16896166 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein ingestion before exercise (PRE)
Number of subjects: 17
Study 16896166 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein ingestion after exercise (POST)
Number of subjects: 17
Study 15099174 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation intentions intervention
Number of subjects: 264
Study 15099174 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 264
Study 17014579 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebotomy therapy (removal of 300-500 mL of blood every 14 days until serum ferritin < 100 microg/L)
Number of subjects: 48
Study 17014579 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebotomy therapy
Number of subjects: 48
Study 17014579 — intervention group
Group type: COMPARATOR
Intervention: Control (follow-up without phlebotomy therapy)
Number of subjects: 48
Study 10513131 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality-based simulator training for DRE
Number of subjects: 2
Study 10513131 — intervention group
Group type: COMPARATOR
Intervention: Modified Merck Procar simulator training for DRE
Number of subjects: 2
Study 8739008 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric consultation
Number of subjects: 104